Chemed: Families of VITAS Patients Say The Company Mismanaged the Care of Their Loved Ones, Causing Physical and Emotional Pain; Former Employees Say VITAS Misrepresented Services When Marketing and Left Patients Alone in Crises; Company Has Been Cited Hundreds of Times by Regulators for Poor Care and Holds Medicare Ratings Well Below National Average Despite Higher-Than-Average Payments

In 2024, Vitas Healthcare, the largest hospice provider in the nation and a subsidiary of Chemed (CHE), was paid by Medicare roughly 26%, or $4,000, more per patient compared with the national average to provide end-of-life care, according to an analysis of Medicare claims data for that year. But that additional revenue has not resulted […]